SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Chrystalina A. Antoniades, Nele Demeyere, Christopher Kennard, Glyn W. Humphreys, Michele T. Hu, Antisaccades and executive dysfunction in early drug-naive Parkinson's disease: The discovery study, Movement Disorders, 2015, 30, 1
  2. 2
    B. Lilleeng, M. Gjerstad, R. Baardsen, I. Dalen, J. P. Larsen, Motor symptoms after deep brain stimulation of the subthalamic nucleus, Acta Neurologica Scandinavica, 2015, 131, 1
  3. 3
    Roy N. Alcalay, Helen Mejia-Santana, Anat Mirelman, Rachel Saunders-Pullman, Deborah Raymond, Christina Palmese, Elise Caccappolo, Laurie Ozelius, Avi Orr-Urtreger, Lorraine Clark, Nir Giladi, Susan Bressman, Karen Marder, Neuropsychological performance in LRRK2 G2019S carriers with Parkinson's disease, Parkinsonism & Related Disorders, 2015, 21, 2, 106

    CrossRef

  4. 4
    Brook Galna, Sue Lord, David J. Burn, Lynn Rochester, Progression of gait dysfunction in incident Parkinson's disease: Impact of medication and phenotype, Movement Disorders, 2015, 30, 1
  5. 5
    Katsuji Kobayashi, Hiroyuki Nakano, Noriko Akiyama, Takashi Maeda, Sanae Yamamori, Pure psychiatric presentation of the Lewy body disease is depression—an analysis of 60 cases verified with myocardial meta-iodobenzylguanidine study, International Journal of Geriatric Psychiatry, 2015, 30, 2
  6. 6
    V. Kotagal, R. L. Albin, M. L. T. M. Muller, R. A. Koeppe, S. Studenski, K. A. Frey, N. I. Bohnen, Advanced Age, Cardiovascular Risk Burden, and Timed Up and Go Test Performance in Parkinson Disease, The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 2014, 69, 12, 1569

    CrossRef

  7. 7
    Spiridon Konitsiotis, Sevasti Bostantjopoulou, Maria Chondrogiorgi, Zoe Katsarou, Georgios Tagaris, Ioannis Mavromatis, Evangelia E. Ntzani, Georgios Mentenopoulos, Clinical characteristics of Parkinson's disease patients in Greece: A multicenter, nation-wide, cross-sectional study, Journal of the Neurological Sciences, 2014, 343, 1-2, 36

    CrossRef

  8. 8
    Sue Lord, Brook Galna, Shirley Coleman, Alison Yarnall, David Burn, Lynn Rochester, Cognition and Gait Show a Selective Pattern of Association Dominated by Phenotype in Incident Parkinson’s Disease, Frontiers in Aging Neuroscience, 2014, 6,

    CrossRef

  9. 9
    H. C. V. Pfeiffer, A. Løkkegaard, M. Zoetmulder, L. Friberg, L. Werdelin, Cognitive impairment in early-stage non-demented Parkinson's disease patients, Acta Neurologica Scandinavica, 2014, 129, 5
  10. 10
    Martina Giuntini, Filippo Baldacci, Eleonora Del Prete, Ubaldo Bonuccelli, Roberto Ceravolo, Diabetes is associated with postural and cognitive domains in Parkinson's disease. Results from a single-center study, Parkinsonism & Related Disorders, 2014, 20, 6, 671

    CrossRef

  11. 11
    Valtteri Kaasinen, Maija Kinos, Juho Joutsa, Marko Seppänen, Tommi Noponen, Differences in striatal dopamine transporter density between tremor dominant and non-tremor Parkinson’s disease, European Journal of Nuclear Medicine and Molecular Imaging, 2014, 41, 10, 1931

    CrossRef

  12. 12
    Marcello Moccia, Sabina Pappatà, Marina Picillo, Roberto Erro, Anna Rita Daniela Coda, Katia Longo, Carmine Vitale, Marianna Amboni, Arturo Brunetti, Giuseppe Capo, Marco Salvatore, Paolo Barone, Maria Teresa Pellecchia, Dopamine transporter availability in motor subtypes of de novo drug-naïve Parkinson’s disease, Journal of Neurology, 2014, 261, 11, 2112

    CrossRef

  13. 13
    Nicolaas I. Bohnen, Kirk A. Frey, Stephanie Studenski, Vikas Kotagal, Robert A. Koeppe, Gregory M. Constantine, Peter J.H. Scott, Roger L. Albin, Martijn L.T.M. Müller, Extra-nigral pathological conditions are common in Parkinson's disease with freezing of gait: An in vivo positron emission tomography study, Movement Disorders, 2014, 29, 9
  14. 14
    Stephen N. Gomperts, Imaging the Role of Amyloid in PD Dementia and Dementia with Lewy Bodies, Current Neurology and Neuroscience Reports, 2014, 14, 8

    CrossRef

  15. 15
    Alberto J. Espay, Peter A. LeWitt, Horacio Kaufmann, Norepinephrine deficiency in Parkinson's disease: The case for noradrenergic enhancement, Movement Disorders, 2014, 29, 14
  16. 16
    Sarah F. Moore, Roger A. Barker, Predictors of Parkinson's disease dementia: Towards targeted therapies for a heterogeneous disease, Parkinsonism & Related Disorders, 2014, 20, S104

    CrossRef

  17. 17
    Lonneke M.L. de Lau, Dagmar Verbaan, Johan Marinus, Jacobus J. van Hilten, Survival in Parkinson's disease. Relation with motor and non-motor features, Parkinsonism & Related Disorders, 2014, 20, 6, 613

    CrossRef

  18. 18
    Abhishek Jaywant, Giovanni Musto, Sandy Neargarder, Karina Stavitsky Gilbert, Alice Cronin-Golomb, The effect of Parkinson’s disease subgroups on verbal and nonverbal fluency, Journal of Clinical and Experimental Neuropsychology, 2014, 36, 3, 278

    CrossRef

  19. 19
    Ling-Ling Chan, Kia-Min Ng, Helmut Rumpel, Stephanie Fook-Chong, Hui-Hua Li, Eng-King Tan, Transcallosal diffusion tensor abnormalities in predominant gait disorder parkinsonism, Parkinsonism & Related Disorders, 2014, 20, 1, 53

    CrossRef

  20. 20
    Brit Mollenhauer, Lynn Rochester, Alice Chen-Plotkin, David Brooks, What can biomarkers tell us about cognition in Parkinson's disease?, Movement Disorders, 2014, 29, 5
  21. 21
    Dana Kim, Jin Hui Paik, Dong-Woon Shin, Hak-Su Kim, Chang-Shin Park, Ju-Hee Kang, What is the Clinical Significance of Cerebrospinal Fluid Biomarkers in Parkinson's disease? Is the Significance Diagnostic or Prognostic?, Experimental Neurobiology, 2014, 23, 4, 352

    CrossRef

  22. 22
    Vikas Kotagal, Roger L. Albin, Martijn L.T.M. Müller, Robert A. Koeppe, Kirk A. Frey, Nicolaas I. Bohnen, Diabetes is associated with postural instability and gait difficulty in Parkinson disease, Parkinsonism & Related Disorders, 2013, 19, 5, 522

    CrossRef

  23. 23
    Anat Mirelman, Talia Heman, Kira Yasinovsky, Avner Thaler, Tanya Gurevich, Karen Marder, Susan Bressman, Anat Bar-Shira, Avi Orr-Urtreger, Nir Giladi, Jeffrey M. Hausdorff, Fall risk and gait in Parkinson's disease: The role of the LRRK2 G2019S mutation, Movement Disorders, 2013, 28, 12
  24. 24
    Y. H. Hiorth, K. Lode, J. P. Larsen, Frequencies of falls and associated features at different stages of Parkinson's disease, European Journal of Neurology, 2013, 20, 1
  25. 25
    Glenn T. Stebbins, Christopher G. Goetz, David J. Burn, Joseph Jankovic, Tien K. Khoo, Barbara C. Tilley, How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson's disease rating scale: Comparison with the unified Parkinson's disease rating scale, Movement Disorders, 2013, 28, 5
  26. 26
    Bernd Müller, Jörg Assmus, Karen Herlofson, Jan Petter Larsen, Ole-Bjørn Tysnes, Importance of motor vs. non-motor symptoms for health-related quality of life in early Parkinson's disease, Parkinsonism & Related Disorders, 2013, 19, 11, 1027

    CrossRef

  27. 27
    Anna R. Schönberger, Michael T. Barbe, Klara Hagelweide, Anne B. Kühn, Gereon R. Fink, Ricarda I. Schubotz, Joint principles of motor and cognitive dysfunction in Parkinson’s disease, Neuropsychologia, 2013, 51, 8, 1417

    CrossRef

  28. 28
    Ganesvaran Ganga, Jane E. Alty, Benjamin G. Clissold, Craig D. McColl, Katrina A. Reardon, Mark Schiff, Peter A. Kempster, Longitudinal study of levodopa in Parkinson's disease: Effects of the advanced disease phase, Movement Disorders, 2013, 28, 4
  29. 29
    Nico Bunzeck, Victoria Singh-Curry, Cindy Eckart, Nikolaus Weiskopf, Richard J. Perry, Peter G. Bain, Emrah Düzel, Masud Husain, Motor phenotype and magnetic resonance measures of basal ganglia iron levels in Parkinson's disease, Parkinsonism & Related Disorders, 2013, 19, 12, 1136

    CrossRef

  30. 30
    Roy N. Alcalay, Anat Mirelman, Rachel Saunders-Pullman, Ming-X Tang, Helen Mejia Santana, Deborah Raymond, Ernest Roos, Martha Orbe-Reilly, Tanya Gurevich, Anat Bar Shira, Mali Gana Weisz, Kira Yasinovsky, Maayan Zalis, Avner Thaler, Andres Deik, Matthew James Barrett, Jose Cabassa, Mark Groves, Ann L. Hunt, Naomi Lubarr, Marta San Luciano, Joan Miravite, Christina Palmese, Rivka Sachdev, Harini Sarva, Lawrence Severt, Vicki Shanker, Matthew Carrington Swan, Jeannie Soto-Valencia, Brooke Johannes, Robert Ortega, Stanley Fahn, Lucien Cote, Cheryl Waters, Pietro Mazzoni, Blair Ford, Elan Louis, Oren Levy, Llency Rosado, Diana Ruiz, Tsvyatko Dorovski, Michael Pauciulo, William Nichols, Avi Orr-Urtreger, Laurie Ozelius, Lorraine Clark, Nir Giladi, Susan Bressman, Karen S. Marder, Parkinson disease phenotype in Ashkenazi jews with and without LRRK2 G2019S mutations, Movement Disorders, 2013, 28, 14
  31. 31
    Martin Niethammer, Chris C. Tang, Yilong Ma, Paul J. Mattis, Ji Hyun Ko, Vijay Dhawan, David Eidelberg, Parkinson's disease cognitive network correlates with caudate dopamine, NeuroImage, 2013, 78, 204

    CrossRef

  32. 32
    David J. Irwin, Virginia M.-Y. Lee, John Q. Trojanowski, Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies, Nature Reviews Neuroscience, 2013, 14, 9, 626

    CrossRef

  33. 33
    Susanna Jakobson Mo, Jan Linder, Lars Forsgren, Henrik Holmberg, Anne Larsson, Katrine Riklund, Pre- and Postsynaptic Dopamine SPECT in Idiopathic Parkinsonian Diseases: A Follow-Up Study, BioMed Research International, 2013, 2013, 1

    CrossRef

  34. 34
    Paulo Bugalho, Miguel Viana-Baptista, Predictors of Cognitive Decline in the Early Stages of Parkinson's Disease: A Brief Cognitive Assessment Longitudinal Study, Parkinson's Disease, 2013, 2013, 1

    CrossRef

  35. 35
    Keisuke Suzuki, Tomoyuki Miyamoto, Masayuki Miyamoto, Yuka Watanabe, Shiho Suzuki, Muneto Tatsumoto, Masaoki Iwanami, Tsubasa Sada, Taro Kadowaki, Ayaka Numao, Kenichi Hashimoto, Hideki Sakuta, Koichi Hirata, Probable rapid eye movement sleep behavior disorder, nocturnal disturbances and quality of life in patients with Parkinson’s disease: a case-controlled study using the rapid eye movement sleep behavior disorder screening questionnaire, BMC Neurology, 2013, 13, 1, 18

    CrossRef

  36. 36
    Paulo Bugalho, Miguel Viana-Baptista, REM sleep behavior disorder and motor dysfunction in Parkinson's disease – A longitudinal study, Parkinsonism & Related Disorders, 2013, 19, 12, 1084

    CrossRef

  37. 37
    C. H. Williams-Gray, S. L. Mason, J. R. Evans, T. Foltynie, C. Brayne, T. W. Robbins, R. A. Barker, The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort, Journal of Neurology, Neurosurgery & Psychiatry, 2013, 84, 11, 1258

    CrossRef

  38. 38
    Yaroslau Compta, Tamas Revesz, Andrew J. Lees, The more cortical amyloid-β, the more postural instability in parkinson's disease: More grist to the mill for a link between walking, falling, and remembering?, Movement Disorders, 2013, 28, 3
  39. 39
    Joe R. Nocera, Elizabeth L. Stegemöller, Irene A. Malaty, Michael S. Okun, Michael Marsiske, Chris J. Hass, Using the Timed Up & Go Test in a Clinical Setting to Predict Falling in Parkinson's Disease, Archives of Physical Medicine and Rehabilitation, 2013, 94, 7, 1300

    CrossRef

  40. 40
    Martijn L.T.M. Müller, Kirk A. Frey, Myria Petrou, Vikas Kotagal, Robert A. Koeppe, Roger L. Albin, Nicolaas I. Bohnen, β-amyloid and postural instability and gait difficulty in Parkinson's disease at risk for dementia, Movement Disorders, 2013, 28, 3
  41. 41
    R. C. Helmich, M. Hallett, G. Deuschl, I. Toni, B. R. Bloem, Cerebral causes and consequences of parkinsonian resting tremor: a tale of two circuits?, Brain, 2012, 135, 11, 3206

    CrossRef

  42. 42
    L. Rochester, A. J. Yarnall, M. R. Baker, R. V. David, S. Lord, B. Galna, D. J. Burn, Cholinergic dysfunction contributes to gait disturbance in early Parkinson's disease, Brain, 2012, 135, 9, 2779

    CrossRef

  43. 43
    Jennifer G. Goldman, Holly Weis, Glenn Stebbins, Bryan Bernard, Christopher G. Goetz, Clinical differences among mild cognitive impairment subtypes in Parkinson's disease, Movement Disorders, 2012, 27, 9
  44. 44
    Domenico Bosco, Massimiliano Plastino, Dario Cristiano, Carmela Colica, Caterina Ermio, Matteo De Bartolo, Pasquale Mungari, Giulia Fonte, Domenico Consoli, Arturo Consoli, Antonietta Fava, Dementia is associated with Insulin Resistance in patients with Parkinson's Disease, Journal of the Neurological Sciences, 2012, 315, 1-2, 39

    CrossRef

  45. 45
    Thuy C. Vu, John G. Nutt, Nicholas H. G. Holford, Disease progress and response to treatment as predictors of survival, disability, cognitive impairment and depression in Parkinson's disease, British Journal of Clinical Pharmacology, 2012, 74, 2
  46. 46
    Marianna Amboni, Paolo Barone, Luigi Iuppariello, Ilaria Lista, Riccardo Tranfaglia, Alfonso Fasano, Marina Picillo, Carmine Vitale, Gabriella Santangelo, Valeria Agosti, Alessandro Iavarone, Giuseppe Sorrentino, Gait patterns in parkinsonian patients with or without mild cognitive impairment, Movement Disorders, 2012, 27, 12
  47. 47
    Nicolaas I Bohnen, Martijn L T M Müller, Vikas Kotagal, Robert A Koeppe, Michael R Kilbourn, Sid Gilman, Roger L Albin, Kirk A Frey, Heterogeneity of cholinergic denervation in Parkinson's disease without dementia, Journal of Cerebral Blood Flow & Metabolism, 2012, 32, 8, 1609

    CrossRef

  48. 48
    Connie Marras, How will epidemiology shape our knowledge of the patterns of disease progression in Parkinson’s disease?, Basal Ganglia, 2012, 2, 4, 171

    CrossRef

  49. 49
    Jan Linder, Britt-Inger Wenngren, Hans Stenlund, Lars Forsgren, Impaired oculomotor function in a community-based patient population with newly diagnosed idiopathic parkinsonism, Journal of Neurology, 2012, 259, 6, 1206

    CrossRef

  50. 50
    Rick C. Helmich, Bastiaan R. Bloem, Ivan Toni, Motor imagery evokes increased somatosensory activity in parkinson's disease patients with tremor, Human Brain Mapping, 2012, 33, 8
  51. 51
    Jong Moon Lee, Seong-Beom Koh, Sung Won Chae, Woo-Keun Seo, Do Young Kwon, Ji Hyun Kim, Kyungmi Oh, Jong Sam Baik, Kun Woo Park, Postural Instability and Cognitive Dysfunction in Early Parkinson's Disease, The Canadian Journal of Neurological Sciences, 2012, 39, 04, 473

    CrossRef

  52. 52
    Thuy C. Vu, John G. Nutt, Nicholas H. G. Holford, Progression of motor and nonmotor features of Parkinson's disease and their response to treatment, British Journal of Clinical Pharmacology, 2012, 74, 2
  53. 53
    Karina Stavitsky, Sandy Neargarder, Yelena Bogdanova, Patrick McNamara, Alice Cronin-Golomb, The Impact of Sleep Quality on Cognitive Functioning in Parkinson's Disease, Journal of the International Neuropsychological Society, 2012, 18, 01, 108

    CrossRef

  54. 54
    Liana G. Apostolova, Steven T. DeKosky, Jeffrey L. Cummings, Neurology in Clinical Practice, 2012,

    CrossRef

  55. 55
    Bernd Müller, Jan Petter Larsen, Tore Wentzel-Larsen, Geir Olve Skeie, Ole-Bjørn Tysnes, Autonomic and sensory symptoms and signs in incident, untreated Parkinson's disease: Frequent but mild, Movement Disorders, 2011, 26, 1
  56. 56
    Stephanie M. van Rooden, Fabrice Colas, Pablo Martínez-Martín, Martine Visser, Dagmar Verbaan, Johan Marinus, Ray K. Chaudhuri, Joost N. Kok, Jacobus J. van Hilten, Clinical subtypes of Parkinson's disease, Movement Disorders, 2011, 26, 1
  57. 57
    Stewart A. Factor, N. Kyle Steenland, Donald S. Higgins, Eric S. Molho, Denise M. Kay, Jennifer Montimurro, Ami R. Rosen, Cyrus P. Zabetian, Haydeh Payami, Disease-related and genetic correlates of psychotic symptoms in Parkinson's disease, Movement Disorders, 2011, 26, 12
  58. 58
    T. Archer, A. Fredriksson, B. Johansson, Exercise alleviates Parkinsonism: clinical and laboratory evidence, Acta Neurologica Scandinavica, 2011, 123, 2
  59. 59
    Michele Poletti, Murat Emre, Ubaldo Bonuccelli, Mild cognitive impairment and cognitive reserve in Parkinson’s disease, Parkinsonism & Related Disorders, 2011, 17, 8, 579

    CrossRef

  60. 60
    Dag Aarsland, Kolbjørn Brønnick, Tormod Fladby, Mild Cognitive Impairment in Parkinson’s Disease, Current Neurology and Neuroscience Reports, 2011, 11, 4, 371

    CrossRef

  61. 61
    Daniel R. Seichepine, Sandy Neargarder, Ivy N. Miller, Tatiana M. Riedel, Grover C. Gilmore, Alice Cronin-Golomb, Relation of Parkinson's Disease Subtypes to Visual Activities of Daily Living, Journal of the International Neuropsychological Society, 2011, 17, 05, 841

    CrossRef

  62. 62
    Magdalena Eriksson Domellöf, Eva Elgh, Lars Forsgren, The relation between cognition and motor dysfunction in drug-naive newly diagnosed patients with Parkinson's disease, Movement Disorders, 2011, 26, 12
  63. 63
    Nicolaas I. Bohnen, Roger L. Albin, White matter lesions in Parkinson disease, Nature Reviews Neurology, 2011, 7, 4, 229

    CrossRef

  64. 64
    Stanley Fahn, Joseph Jankovic, Mark Hallett, Principles and Practice of Movement Disorders, 2011,

    CrossRef

  65. 65
    Kathleen L. Poston, David Eidelberg, 18F-Fluorodeoxyglucose PET in the Evaluation of Parkinson Disease, PET Clinics, 2010, 5, 1, 55

    CrossRef

  66. 66
    Krisztina K. Johansen, Linda R. White, Sigrid B. Sando, Jan O. Aasly, Biomarkers: Parkinson disease with dementia and dementia with Lewy bodies, Parkinsonism & Related Disorders, 2010, 16, 5, 307

    CrossRef

  67. 67
    Karen Marder, Cognitive impairment and dementia in Parkinson's disease, Movement Disorders, 2010, 25, S1
  68. 68
    C. Rossi, D. Frosini, D. Volterrani, P. De Feo, E. Unti, V. Nicoletti, L. Kiferle, U. Bonuccelli, R. Ceravolo, Differences in nigro-striatal impairment in clinical variants of early Parkinson’s disease: evidence from a FP-CIT SPECT study, European Journal of Neurology, 2010, 17, 4
  69. 69
    Jan Linder, Hans Stenlund, Lars Forsgren, Incidence of Parkinson's disease and parkinsonism in northern Sweden: A population-based study, Movement Disorders, 2010, 25, 3
  70. 70
    Ann B. Sollinger, Felicia C. Goldstein, James J. Lah, Allan I. Levey, Stewart A. Factor, Mild cognitive impairment in Parkinson's disease: Subtypes and motor characteristics, Parkinsonism & Related Disorders, 2010, 16, 3, 177

    CrossRef

  71. 71
    Angie A Kehagia, Roger A Barker, Trevor W Robbins, Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease, The Lancet Neurology, 2010, 9, 12, 1200

    CrossRef

  72. 72
    Stanley Fahn, Parkinson's disease: 10 years of progress, 1997–2007, Movement Disorders, 2010, 25, S1
  73. 73
    Susanna Jakobson Mo, Jan Linder, Lars Forsgren, Anne Larsson, Lennart Johansson, Katrine Riklund, Pre- and postsynaptic dopamine SPECT in the early phase of idiopathic parkinsonism: a population-based study, European Journal of Nuclear Medicine and Molecular Imaging, 2010, 37, 11, 2154

    CrossRef

  74. 74
    Joe R. Nocera, Catherine Price, Hubert H. Fernandez, Shinichi Amano, Srikant Vallabhajosula, Michael S. Okun, Nelson Hwynn, Chris J. Hass, Tests of dorsolateral frontal function correlate with objective tests of postural stability in early to moderate stage Parkinson’s disease, Parkinsonism & Related Disorders, 2010, 16, 9, 590

    CrossRef

  75. 75
    Dag Aarsland, Martin Wilhelm Kurz, The epidemiology of dementia associated with Parkinson disease, Journal of the Neurological Sciences, 2010, 289, 1-2, 18

    CrossRef

  76. 76
    Dag Aarsland, Martin Wilhelm Kurz, The Epidemiology of Dementia Associated with Parkinson's Disease, Brain Pathology, 2010, 20, 3
  77. 77
    Shen-Yang Lim, Anthony E. Lang, The nonmotor symptoms of Parkinson's disease—An overview, Movement Disorders, 2010, 25, S1
  78. 78
    David John Burn, MOVEMENT DISORDERS 4, 2010,

    CrossRef

  79. 79
    E. Elgh, M. Domellöf, J. Linder, M. Edström, H. Stenlund, L. Forsgren, Cognitive function in early Parkinson’s disease: a population-based study, European Journal of Neurology, 2009, 16, 12
  80. 80
    Jan Linder, Richard Birgander, Ingegerd Olsson, Katrine Riklund, Ann-Katrine Larsson, Mona Edström, Hans Stenlund, Lars Forsgren, Degenerative changes were common in brain magnetic resonance imaging in patients with newly diagnosed Parkinson’s disease in a population-based cohort, Journal of Neurology, 2009, 256, 10, 1671

    CrossRef

  81. 81
    Miguel Fernandes Gago, M. C. Garrett, M. R. Fonseca, M. J. Rosas, M. F. Simões, S. Vieira, F. Botelho, How do cognitive and axial motor signs correlate in Parkinson’s disease? A 6-year prospective study, Journal of Neurology, 2009, 256, 10, 1655

    CrossRef

  82. 82
    Stephanie M. van Rooden, Martine Visser, Dagmar Verbaan, Johan Marinus, Jacobus J. van Hilten, Motor patterns in Parkinson's disease: A data-driven approach, Movement Disorders, 2009, 24, 7
  83. 83
    Shilpa Chitnis, Jayaraman Rao, Rivastigmine in Parkinson's disease dementia, Expert Opinion on Drug Metabolism & Toxicology, 2009, 5, 8, 941

    CrossRef

  84. 84
    J.S.A.M. Reijnders, U. Ehrt, R. Lousberg, D. Aarsland, A.F.G. Leentjens, The association between motor subtypes and psychopathology in Parkinson's disease, Parkinsonism & Related Disorders, 2009, 15, 5, 379

    CrossRef

  85. 85
    C. Tessa, M. Giannelli, R. Della Nave, C. Lucetti, C. Berti, A. Ginestroni, U. Bonuccelli, M. Mascalchi, A Whole-Brain Analysis in De Novo Parkinson Disease, American Journal of Neuroradiology, 2008, 29, 4, 674

    CrossRef

  86. 86
    Leslie W. Ferguson, Michele L. Rajput, Nazeem Muhajarine, Syed M. Shah, Alexander Rajput, Clinical features at first visit and rapid disease progression in Parkinson's disease, Parkinsonism & Related Disorders, 2008, 14, 5, 431

    CrossRef

  87. 87
    Rufus O. Akinyemi, Njideka N. Okubadejo, Joshua O. Akinyemi, Mayowa O. Owolabi, Lukman F. Owolabi, Adesola Ogunniyi, Cognitive dysfunction in Nigerians with Parkinson's disease, Movement Disorders, 2008, 23, 10
  88. 88
    Dag Aarsland, Mona K Beyer, Martin W Kurz, Dementia in Parkinsonʼs disease, Current Opinion in Neurology, 2008, 21, 6, 676

    CrossRef

  89. 89
    E. Lyros, L. Messinis, P. Papathanasopoulos, Does motor subtype influence neurocognitive performance in Parkinson’s disease without dementia?, European Journal of Neurology, 2008, 15, 3
  90. 90
    Wolfgang Oertel, Werner Poewe, Erik Wolters, Peter Paul De Deyn, Murat Emre, Courtney Kirsch, Chuanchieh Hsu, Sibel Tekin, Roger Lane, Effects of Rivastigmine on Tremor and Other Motor Symptoms in Patients with Parkinson’s Disease Dementia, Drug Safety, 2008, 31, 1, 79

    CrossRef

  91. 91
    Guido Alves, Elin Bjelland Forsaa, Kenn Freddy Pedersen, Michaela Dreetz Gjerstad, Jan Petter Larsen, Epidemiology of Parkinson’s disease, Journal of Neurology, 2008, 255, S5, 18

    CrossRef

  92. 92
    M.K. Beyer, D. Aarsland, Grey matter atrophy in early versus late dementia in Parkinson's disease, Parkinsonism & Related Disorders, 2008, 14, 8, 620

    CrossRef

  93. 93
    Alexander I. Tröster, Neuropsychological Characteristics of Dementia with Lewy Bodies and Parkinson’s Disease with Dementia: Differentiation, Early Detection, and Implications for “Mild Cognitive Impairment” and Biomarkers, Neuropsychology Review, 2008, 18, 1, 103

    CrossRef

  94. 94
    Christopher G. Goetz, Murat Emre, Bruno Dubois, Parkinson's disease dementia: Definitions, guidelines, and research perspectives in diagnosis, Annals of Neurology, 2008, 64, S2
  95. 95
    Connie Marras, Michael P. McDermott, Paula A. Rochon, Caroline M. Tanner, Gary Naglie, Anthony E. Lang, Predictors of deterioration in health-related quality of life in Parkinson's disease: Results from the DATATOP trial, Movement Disorders, 2008, 23, 5
  96. 96
    Thomas Eckert, Chengke Tang, David Eidelberg, Assessment of the progression of Parkinson's disease: a metabolic network approach, The Lancet Neurology, 2007, 6, 10, 926

    CrossRef

  97. You have free access to this content97
    Murat Emre, Dag Aarsland, Richard Brown, David J. Burn, Charles Duyckaerts, Yoshikino Mizuno, Gerald Anthony Broe, Jeffrey Cummings, Dennis W. Dickson, Serge Gauthier, Jennifer Goldman, Christopher Goetz, Amos Korczyn, Andrew Lees, Richard Levy, Irene Litvan, Ian McKeith, Warren Olanow, Werner Poewe, Niall Quinn, Christina Sampaio, Eduardo Tolosa, Bruno Dubois, Clinical diagnostic criteria for dementia associated with Parkinson's disease, Movement Disorders, 2007, 22, 12
  98. 98
    Anke H Snijders, Bart P van de Warrenburg, Nir Giladi, Bastiaan R Bloem, Neurological gait disorders in elderly people: clinical approach and classification, The Lancet Neurology, 2007, 6, 1, 63

    CrossRef

  99. 99
    Tjalf Ziemssen, Heinz Reichmann, Non-motor dysfunction in Parkinson's disease, Parkinsonism & Related Disorders, 2007, 13, 6, 323

    CrossRef

  100. 100
    Yvette A. M. Grimbergen, Arlène D. Speelman, Marjolein A. van der Marck, Yvonne Schoon, Bastiaan R. Bloem, Gait, Postural Instability, and Freezing,